Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Short Communication
  • Published:

The identification of an internal ribosomal entry site in the 5′-untranslated region of p53 mRNA provides a novel mechanism for the regulation of its translation following DNA damage

Abstract

The tumor suppressor p53 plays a crucial role in maintaining the genetic integrity of the cell and in suppressing cell transformation. Its cellular levels are usually low and rise substantially in response to DNA damage. Although research on p53 induction following DNA damage has mainly focused on the post-translational modification of p53 by Mdm2, it is known that protein translation also contributes to p53 induction. However, the mechanisms underlying translational regulation of the p53 protein in response to DNA damage are still poorly understood. We show that p53 synthesis increases dramatically in MCF-7 cells treated with etoposide. Interestingly, this increase is accompanied by an increase in the association of the translation initiation factor eIF-4E with its binding protein 4E-BP1, an inhibitor of cap-dependent protein translation. We further identified an internal ribosomal entry site (IRES) located in the 5′-untranslated region of the p53 transcript, that is capable of driving the cap-independent translation of a downstream cistron encoding Firefly luciferase in a dicistronic expression vector. Moreover, we found that the activity of the IRES element increases in response to etoposide-induced DNA damage in MCF-7 cells. These findings provide a novel mechanism for the regulation of p53 translation in response to DNA damage.

This is a preview of subscription content, access via your institution

Access options

Rent or buy this article

Prices vary by article type

from$1.95

to$39.95

Prices may be subject to local taxes which are calculated during checkout

Figure 1
Figure 2
Figure 3
Figure 4

Similar content being viewed by others

References

  • Fu L, Benchimol S . (1997). EMBO J 16: 4117–4125.

  • Fu L, Ma W, Benchimol S . (1999). Oncogene 18: 6419–6424.

  • Giaccia AJ, Kastan MB . (1998). Genes Dev 12: 2973–2983.

  • Gingras AC, Raught B, Sonenberg N . (1999). Annu Rev Biochem 68: 913–963.

  • Hellen CU, Sarnow P . (2001). Genes Dev 15: 1593–1612.

  • Holcik M . (2004). Curr Cancer Drug Targets 4: 299–311.

  • Holcik M, Lefebvre C, Yeh C, Chow T, Korneluk RG . (1999). Nat Cell Biol 1: 190–192.

  • Kastan MB, Onyekwere O, Sidransky D, Vogelstein B, Craig RW . (1991). Cancer Res 51: 6304–6311.

  • Komar AA, Hatzoglou M . (2005). J Biol Chem 4: 4.

  • Kumar V, Sabatini D, Pandey P, Gingras AC, Majumder PK, Kumar M et al. (2000). J Biol Chem 275: 10779–10787.

  • Lawrence Jr JC, Abraham RT . (1997). Trends Biochem Sci 22: 345–349.

  • Mazan-Mamczarz K, Galban S, Lopez de Silanes I, Martindale JL, Atasoy U, Keene JD et al. (2003). Proc Natl Acad Sci USA 100: 8354–8359.

  • Miskimins WK, Wang G, Hawkinson M, Miskimins R . (2001). Mol Cell Biol 21: 4960–4967.

  • Mosner J, Mummenbrauer T, Bauer C, Sczakiel G, Grosse F, Deppert W . (1995). EMBO J 14: 4442–4449.

  • Mothe-Satney I, Yang D, Fadden P, Haystead TA, Lawrence Jr JC . (2000). Mol Cell Biol 20: 3558–3567.

  • Mukhopadhyay D, Houchen CW, Kennedy S, Dieckgraefe BK, Anant S . (2003). Mol Cell 11: 113–126.

  • Pyronnet S, Pradayrol L, Sonenberg N . (2000). Mol Cell 5: 607–616.

  • Quinn JE, Kennedy RD, Mullan PB, Gilmore PM, Carty M, Johnston PG et al. (2003). Cancer Res 63: 6221–6228.

  • Schumacher B, Hanazawa M, Lee MH, Nayak S, Volkmann K, Hofmann R et al. (2005). Cell 120: 357–368.

  • Sherrill KW, Byrd MP, Van Eden ME, Lloyd RE . (2004). J Biol Chem 279: 29066–29074.

  • Spriggs KA, Bushell M, Mitchell SA, Willis AE . (2005). Cell Death Differ 12: 585–591.

  • Stoneley M, Paulin FE, Le Quesne JP, Chappell SA, Willis AE . (1998). Oncogene 16: 423–428.

  • Sullivan NF, Willis AE . (1989). Oncogene 4: 1497–1502.

  • Takagi M, Absalon MJ, McLure KG, Kastan MB . (2005). Cell 123: 49–63.

  • Tuck SP, Crawford L . (1989). Mol Cell Biol 9: 2163–2172.

  • Vogelstein B, Lane D, Levine AJ . (2000). Nature 408: 307–310.

  • Yang DQ, Kastan MB . (2000). Nat Cell Biol 2: 893–898.

Download references

Acknowledgements

We thank Dr Michael B Kastan for the pRST/hUTR-luc-plus vector and for his advice as well as Dr Anne Willis for kindly providing us with the pRF and pREMCVF constructs. We also thank Dr Keith Miskimins and Dr Ronald Lindahl for critical reading of this manuscript. This work was supported by a start-up fund received by D-Q Yang from the University of South Dakota, Sanford School of Medicine.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to D-Q Yang.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Yang, DQ., Halaby, MJ. & Zhang, Y. The identification of an internal ribosomal entry site in the 5′-untranslated region of p53 mRNA provides a novel mechanism for the regulation of its translation following DNA damage. Oncogene 25, 4613–4619 (2006). https://doi.org/10.1038/sj.onc.1209483

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/sj.onc.1209483

Keywords

This article is cited by

Search

Quick links